Risk factors
Black Diamond Therapeutics (BDTX) risk factors
Item 1A of every Black Diamond Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors75 risks1 new2 dropped16 reworded
Company added sustainability and ESG compliance risks while dropping companion diagnostic requirements.
Filed Mar 16, 2026 - FY2024 10-K risk factors76 risks
Precision medicine oncology development targeting genetically defined cancers using the MAP drug discovery engine dominates the business.
Filed Mar 06, 2025